EP Patent

EP2970101B2 — Prodrugs of fumarates and their use in treating various deseases

Assigned to Alkermes Pharma Ireland Ltd · Expires 2025-09-03 · 1y expired

What this patent protects

Patent listed against Vumerity.

Drugs covered by this patent

Vumerity (DIROXIMEL FUMARATE) · Biogen

Patent Metadata

Patent number: EP2970101B2
Jurisdiction: EP
Classification: —
Expires: 2025-09-03
Drug substance claim: No
Drug product claim: No
Assignee: Alkermes Pharma Ireland Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.